These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 34044277)

  • 1. The pathogenesis, models and therapeutic advances of primary biliary cholangitis.
    Li H; Guan Y; Han C; Zhang Y; Liu Q; Wei W; Ma Y
    Biomed Pharmacother; 2021 Aug; 140():111754. PubMed ID: 34044277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Obeticholic acid for the treatment of primary biliary cholangitis.
    Ali AH; Lindor KD
    Expert Opin Pharmacother; 2016 Sep; 17(13):1809-15. PubMed ID: 27468093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Management of Primary Biliary Cholangitis-Strategies and Evolving Trends.
    Gao L; Wang L; Woo E; He X; Yang G; Bowlus C; Leung PSC; Gershwin ME
    Clin Rev Allergy Immunol; 2020 Oct; 59(2):175-194. PubMed ID: 31713023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Pathogenesis of Primary Biliary Cholangitis: A Comprehensive Review.
    Lleo A; Leung PSC; Hirschfield GM; Gershwin EM
    Semin Liver Dis; 2020 Feb; 40(1):34-48. PubMed ID: 31537031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immune pathogenesis of primary biliary cholangitis].
    Zhang MY; Zhao J; Xie H; Liang QS; Zou ZS; Sun Y
    Zhonghua Gan Zang Bing Za Zhi; 2021 Jun; 29(6):500-504. PubMed ID: 34225423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism-based target therapy in primary biliary cholangitis: opportunities before liver cirrhosis?
    Yang Y; He X; Rojas M; Leung PSC; Gao L
    Front Immunol; 2023; 14():1184252. PubMed ID: 37325634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring Advanced Therapies for Primary Biliary Cholangitis: Insights from the Gut Microbiota-Bile Acid-Immunity Network.
    Guo Z; He K; Pang K; Yang D; Lyu C; Xu H; Wu D
    Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Innate immunity and primary biliary cirrhosis: activated invariant natural killer T cells exacerbate murine autoimmune cholangitis and fibrosis.
    Wu SJ; Yang YH; Tsuneyama K; Leung PS; Illarionov P; Gershwin ME; Chuang YH
    Hepatology; 2011 Mar; 53(3):915-25. PubMed ID: 21374662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Environmental factors and primary biliary cirrhosis].
    Chen LP; Zhao H; Lyu B; Cheng JL
    Zhonghua Gan Zang Bing Za Zhi; 2016 Jul; 24(7):541-544. PubMed ID: 27784437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does antimitochondrial antibody status affect response to treatment in patients with primary biliary cirrhosis? Outcomes of ursodeoxycholic acid therapy and liver transplantation.
    Kim WR; Poterucha JJ; Jorgensen RA; Batts KP; Homburger HA; Dickson ER; Krom RA; Wiesner RH; Lindor KD
    Hepatology; 1997 Jul; 26(1):22-6. PubMed ID: 9214447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The challenges of primary biliary cholangitis: What is new and what needs to be done.
    Terziroli Beretta-Piccoli B; Mieli-Vergani G; Vergani D; Vierling JM; Adams D; Alpini G; Banales JM; Beuers U; Björnsson E; Bowlus C; Carbone M; Chazouillères O; Dalekos G; De Gottardi A; Harada K; Hirschfield G; Invernizzi P; Jones D; Krawitt E; Lanzavecchia A; Lian ZX; Ma X; Manns M; Mavilio D; Quigley EM; Sallusto F; Shimoda S; Strazzabosco M; Swain M; Tanaka A; Trauner M; Tsuneyama K; Zigmond E; Gershwin ME
    J Autoimmun; 2019 Dec; 105():102328. PubMed ID: 31548157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary biliary cholangitis: primary autoimmune disease or primary secretory defect.
    Floreani A; Gabbia D; De Martin S
    Expert Rev Gastroenterol Hepatol; 2023; 17(9):863-870. PubMed ID: 37515436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. From pathogenesis to novel therapies in the treatment of primary biliary cholangitis.
    Ronca V; Carbone M; Bernuzzi F; Malinverno F; Mousa HS; Gershwin ME; Invernizzi P
    Expert Rev Clin Immunol; 2017 Dec; 13(12):1121-1131. PubMed ID: 28994348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Advances in the treatment of primary biliary cholangitis].
    Li YM; Wang QX; Ma X
    Zhonghua Gan Zang Bing Za Zhi; 2017 Nov; 25(11):805-809. PubMed ID: 29325272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An Update on the Treatment and Follow-up of Patients with Primary Biliary Cholangitis.
    Burman BE; Jhaveri MA; Kowdley KV
    Clin Liver Dis; 2017 Nov; 21(4):709-723. PubMed ID: 28987258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis and management of primary biliary cirrhosis.
    Ali AH; Carey EJ; Lindor KD
    Expert Rev Clin Immunol; 2014 Dec; 10(12):1667-78. PubMed ID: 25382237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunological abnormalities in patients with primary biliary cholangitis.
    Ma WT; Chen DK
    Clin Sci (Lond); 2019 Mar; 133(6):741-760. PubMed ID: 30890652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary biliary cholangitis in China.
    Wang L; Gershwin ME; Wang FS
    Curr Opin Gastroenterol; 2016 May; 32(3):195-203. PubMed ID: 26885951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A brief review on prognostic models of primary biliary cholangitis.
    Chen S; Duan W; You H; Jia J
    Hepatol Int; 2017 Sep; 11(5):412-418. PubMed ID: 28913620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Animal models of primary biliary cirrhosis.
    Katsumi T; Tomita K; Leung PS; Yang GX; Gershwin ME; Ueno Y
    Clin Rev Allergy Immunol; 2015 Jun; 48(2-3):142-53. PubMed ID: 25771770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.